Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
FDF
0
FDA Orange Book
0
Europe
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. (2s,2s)-2-benzhydryl-n-(5-tert-butyl-2-methoxybenzyl)quinuclidin-3-amine Citrate Monohydrate
2. (2s,3s)-2-benzhydryl-n-(5-(tert-butyl)-2-methoxybenzyl)quinuclidin-3-amine 2-hydroxypropane-1,2,3-tricarboxylate Hydrate
3. (2s,3s)-2-benzhydryl-n-(5-tert-butyl-2-methoxybenzyl)quinuclidin-3-amine Citrate Monohydrate
4. 2-benzhydryl-n-(5-tert-butyl-2-methoxybenzyl)quinuclidin-3-amine Citrate Monohydrate
5. Maropitant
1. 359875-09-5
2. Cerenia
3. Maropitant Citrate Hydrate
4. Maropitant Citrate [usan]
5. Cj-11,972
6. Maropitant Citrate Monohydrate
7. Lxn6s3999x
8. Cj-11972
9. Maropitant Citrate (usan)
10. (2s,3s)-2-benzhydryl-n-[(5-tert-butyl-2-methoxyphenyl)methyl]-1-azabicyclo[2.2.2]octan-3-amine Citrate Hydrate
11. (2s,3s)-n-(5-(1,1-dimethylethyl)-2-methoxybenzyl)-2-(diphenylmethyl)-1-azabicyclo(2.2.2)octan-3-amine 2-hydroxy-1,2,3-propanetricarboxylate (1:1), Monohydrate
12. 1-azabicyclo(2.2.2)octan-3-amine, N-((5-(1,1-dimethylethyl)-2-methoxyphenyl)methyl)-2-(diphenylmethyl)-, (2s,3s)-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1), Monohydrate
13. Unii-lxn6s3999x
14. Starbld0016570
15. Schembl4184310
16. Chembl2107353
17. Dtxsid70957411
18. Ex-a3585
19. Bs-49286
20. Maropitant Citrate Monohydrate [mi]
21. D04860
22. E83993
23. Maropitant Citrate [ema Epar Veterinary]
24. (2-benzhydryl-1-aza-bicyclo(2.2.2)oct-3-yl)-(5-tert-butyl-2-methoxybenzyl)amine
25. (2s,3s)-2-benzhydryl-n-(5-tert-butyl-2-methoxybenzyl) Quinuclidin-3-amine Citrate Monohydrate
26. (2s,3s)-2-benzhydryl-n-[(5-tert-butyl-2-methoxyphenyl)methyl]-1-azabicyclo[2.2.2]octan-3-amine;2-hydroxypropane-1,2,3-tricarboxylic Acid;hydrate
27. 2-hydroxypropane-1,2,3-tricarboxylic Acid--n-[(5-tert-butyl-2-methoxyphenyl)methyl]-2-(diphenylmethyl)-1-azabicyclo[2.2.2]octan-3-amine--water (1/1/1)
Molecular Weight | 678.8 g/mol |
---|---|
Molecular Formula | C38H50N2O9 |
Hydrogen Bond Donor Count | 6 |
Hydrogen Bond Acceptor Count | 11 |
Rotatable Bond Count | 13 |
Exact Mass | 678.35163118 g/mol |
Monoisotopic Mass | 678.35163118 g/mol |
Topological Polar Surface Area | 158 Ų |
Heavy Atom Count | 49 |
Formal Charge | 0 |
Complexity | 848 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 2 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 3 |
* Tablets:
Dogs:
- For the prevention of nausea induced by chemotherapy.
- For the prevention of vomiting induced by motion sickness.
- For the prevention and treatment of vomiting, in conjunction with Cerenia solution for injection and in combination with other supportive measures.
* Solution for injection:
Dogs:
- For the treatment and prevention of nausea induced by chemotherapy.
- For the prevention of vomiting except that induced by motion sickness.
- For the treatment of vomiting, in combination with other supportive measures.
- For the prevention of perioperative nausea and vomiting and improvement in recovery from general anaesthesia after use of the -opiate receptor agonist morphine.
Cats:
- For the prevention of vomiting and the reduction of nausea, except that induced by motion sickness.
- For the treatment of vomiting, in combination with other supportive measures.
Antiemetics
Drugs used to prevent NAUSEA or VOMITING. (See all compounds classified as Antiemetics.)
QA04AD90
ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.
Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.
VMF Number : 6413
Submission : 2021-03-25
Status : Active
Type : II
VMF Number : 6371
Submission : 2020-05-06
Status : Active
Type : II
VMF Number : 6372
Submission : 2020-05-06
Status : Active
Type : II
VMF Number : 6488
Submission : 2022-11-02
Status : Active
Type : II
VMF Number : 6491
Submission : 2022-11-09
Status : Active
Type : II
VMF Number : 6413
Submission : 2021-03-25
Status : Active
Type : II
VMF Number : 6305
Submission : 2019-04-12
Status : Active
Type : II
VMF Number : 6549
Submission : 2023-08-02
Status : Active
Type : II
VMF Number : 6145
Submission : 2016-03-08
Status : Active
Type : II
VMF Number : 5825
Submission : 2005-01-14
Status : Active
Type : II
VMF Number : 6277
Submission : 2018-10-29
Status : Active
Type : II
ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.
About the Company : Established in 1982, ChemWerth is a US-headquartered full-service generic active pharmaceutical ingredient (API) development and supply company. ChemWerth offers cGMP-quality APIs ...
Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.
About the Company : Established in 1994, Rochem is a distributor of pharmaceutical, food, nutritional and animal health ingredients to some of the largest companies in the world. It sources high-quali...
About the Company : Suanfarma founded in 1993, is a B2B life science partner committed to health & innovation by developing, manufacturing, & distributing high-quality APIs for the pharmaceutical indu...
About the Company : Alivira Animal Health Limited has emerged as India's largest and 1st Global integrated animal health company specialising in manufacturing of Active Pharmaceutical Ingredients (API...
About the Company : Medilux Laboratories has been providing quality back-end support to the pharmaceutical industry since our inception in 1988. Our resources are dedicated to promoting better health ...
About the Company : Sichuan Qingmu Pharmaceutical Co., Ltd, is a FDA approved cGMP factory in China, focusing on APIs’ production. The products are mainly Oncology APIs, Cardiovascular APIs, and Vet...
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Regulatory Info :
Registration Country : Canada
Brand Name : EMAVERT
Dosage Form : SOLUTION
Dosage Strength : 10MG/ML
Packaging :
Approval Date :
Application Number : 2529564
Regulatory Info :
Registration Country : Canada
Regulatory Info :
Registration Country : Canada
MAROPITANT (MAROPITANT CITRATE)
Brand Name : CERENIA
Dosage Form : TABLET
Dosage Strength : 16MG
Packaging : 4
Approval Date :
Application Number : 2299496
Regulatory Info :
Registration Country : Canada
Regulatory Info :
Registration Country : Canada
MAROPITANT (MAROPITANT CITRATE)
Brand Name : CERENIA
Dosage Form : TABLET
Dosage Strength : 24MG
Packaging : 4
Approval Date :
Application Number : 2299518
Regulatory Info :
Registration Country : Canada
Regulatory Info :
Registration Country : Canada
MAROPITANT (MAROPITANT CITRATE)
Brand Name : CERENIA
Dosage Form : TABLET
Dosage Strength : 60MG
Packaging : 4
Approval Date :
Application Number : 2299526
Regulatory Info :
Registration Country : Canada
Regulatory Info :
Registration Country : Canada
MAROPITANT (MAROPITANT CITRATE)
Brand Name : CERENIA
Dosage Form : TABLET
Dosage Strength : 160MG
Packaging : 4
Approval Date :
Application Number : 2299534
Regulatory Info :
Registration Country : Canada
Regulatory Info :
Registration Country : Canada
MAROPITANT (MAROPITANT CITRATE)
Brand Name : CERENIA
Dosage Form : SOLUTION
Dosage Strength : 10MG/ML
Packaging : 20ML
Approval Date :
Application Number : 2299542
Regulatory Info :
Registration Country : Canada
Related Excipient Companies
Excipients by Applications
Market Place
Reply
08 Nov 2024
Reply
06 Sep 2024
Reply
30 Jun 2023
Reply
28 Jul 2022
Reply
07 Dec 2020
Reply
18 May 2017
Patents & EXCLUSIVITIES
Patent Expiration Date : 2012-04-28
Date Granted : 1998-10-27
Brand Name : CERENIA
Patent Number : 2102179
Filing Date : 1992-04-28
Strength per Unit : 16mg
Dosage Form : Tablet
Human Or VET : Veterinary
Route of Administration : Oral
Patent Expiration Date : 2012-04-28
Date Granted : 1998-10-27
Patent Expiration Date : 2012-04-28
Date Granted : 1998-10-27
Brand Name : CERENIA
Patent Number : 2102179
Filing Date : 1992-04-28
Strength per Unit : 24mg
Dosage Form : Tablet
Human Or VET : Veterinary
Route of Administration : Oral
Patent Expiration Date : 2012-04-28
Date Granted : 1998-10-27
Patent Expiration Date : 2012-04-28
Date Granted : 1998-10-27
Brand Name : CERENIA
Patent Number : 2102179
Filing Date : 1992-04-28
Strength per Unit : 60mg
Dosage Form : Tablet
Human Or VET : Veterinary
Route of Administration : Oral
Patent Expiration Date : 2012-04-28
Date Granted : 1998-10-27
Patent Expiration Date : 2012-04-28
Date Granted : 1998-10-27
Brand Name : CERENIA
Patent Number : 2102179
Filing Date : 1992-04-28
Strength per Unit : 160mg
Dosage Form : Tablet
Human Or VET : Veterinary
Route of Administration : Oral
Patent Expiration Date : 2012-04-28
Date Granted : 1998-10-27
Patent Expiration Date : 2012-04-28
Date Granted : 1998-10-27
Brand Name : CERENIA
Patent Number : 2102179
Filing Date : 1992-04-28
Strength per Unit : 10mg / ml
Dosage Form : solution
Human Or VET : Veterinary
Route of Administration : subcutaneous
Patent Expiration Date : 2012-04-28
Date Granted : 1998-10-27
Patent Expiration Date : 2020-05-18
Date Granted : 2006-12-19
Brand Name : CERENIA
Patent Number : 2372238
Filing Date : 2000-05-18
Strength per Unit : 16mg
Dosage Form : Tablet
Human Or VET : Veterinary
Route of Administration : Oral
Patent Expiration Date : 2020-05-18
Date Granted : 2006-12-19
Patent Expiration Date : 2020-05-18
Date Granted : 2006-12-19
Brand Name : CERENIA
Patent Number : 2372238
Filing Date : 2000-05-18
Strength per Unit : 24mg
Dosage Form : Tablet
Human Or VET : Veterinary
Route of Administration : Oral
Patent Expiration Date : 2020-05-18
Date Granted : 2006-12-19
Patent Expiration Date : 2020-05-18
Date Granted : 2006-12-19
Brand Name : CERENIA
Patent Number : 2372238
Filing Date : 2000-05-18
Strength per Unit : 60mg
Dosage Form : Tablet
Human Or VET : Veterinary
Route of Administration : Oral
Patent Expiration Date : 2020-05-18
Date Granted : 2006-12-19
Patent Expiration Date : 2020-05-18
Date Granted : 2006-12-19
Brand Name : CERENIA
Patent Number : 2372238
Filing Date : 2000-05-18
Strength per Unit : 160mg
Dosage Form : Tablet
Human Or VET : Veterinary
Route of Administration : Oral
Patent Expiration Date : 2020-05-18
Date Granted : 2006-12-19
Patent Expiration Date : 2020-05-18
Date Granted : 2006-12-19
Brand Name : CERENIA
Patent Number : 2372238
Filing Date : 2000-05-18
Strength per Unit : 10mg / ml
Dosage Form : solution
Human Or VET : Veterinary
Route of Administration : subcutaneous
Patent Expiration Date : 2020-05-18
Date Granted : 2006-12-19
ABOUT THIS PAGE
A Maropitant manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Maropitant, including repackagers and relabelers. The FDA regulates Maropitant manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Maropitant API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Maropitant manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Maropitant supplier is an individual or a company that provides Maropitant active pharmaceutical ingredient (API) or Maropitant finished formulations upon request. The Maropitant suppliers may include Maropitant API manufacturers, exporters, distributors and traders.
click here to find a list of Maropitant suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Maropitant as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Maropitant API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Maropitant as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Maropitant and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Maropitant NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Maropitant suppliers with NDC on PharmaCompass.
Maropitant Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Maropitant GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Maropitant GMP manufacturer or Maropitant GMP API supplier for your needs.
A Maropitant CoA (Certificate of Analysis) is a formal document that attests to Maropitant's compliance with Maropitant specifications and serves as a tool for batch-level quality control.
Maropitant CoA mostly includes findings from lab analyses of a specific batch. For each Maropitant CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Maropitant may be tested according to a variety of international standards, such as European Pharmacopoeia (Maropitant EP), Maropitant JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Maropitant USP).
LOOKING FOR A SUPPLIER?